By Will Feuer Celularity Chief Executive Robert Hariri said the biotechnology company expects to report 2023 revenue that is 23%…
Stay informed with free updatesSimply sign up to the Climate change myFT Digest -- delivered directly to your inbox.ING, the…
By Josh Beckerman TransCode Therapeutics shares were recently down 49% to $1.10 after the pricing of a $7.25 million public…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.US lawmakers…
Spirit Airlines stock was falling sharply again Thursday as the ultra-low-cost carrier’s predicament worsened. The shares have plunged this week…
Stay informed with free updatesSimply sign up to the German economy myFT Digest -- delivered directly to your inbox.Germany is…
Stocks closed up Thursday, getting a boost from shares in the tech sector. The tech-heavy Nasdaq Composite turned positive for…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.China has…
Sign in to your account
